Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update ...
The following is a summary of "Colorectal cancer incidence in steatotic liver disease (MASLD, MetALD, and ALD)," published in ...
GB News on MSN2d
Royal author Katie Nicholl reveals how she fought rare liver cancer after chance discoveryVanity Fair Royal Correspondent Katie Nicholl has spoken about how her life was saved by surgery after she was diagnosed with ...
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...
Scientists at EMBL and DKFZ have discovered how cells in the liver maintain their identity and avoid becoming tumour cells ...
I saw this as something that I thought would change me,” said Clark Gamblin, a cancer surgeon in Milwaukee. “And change me ...
1d
News Medical on MSNOral vancomycin induces PSC-IBD remission, driving gut microbiome and metabolic shiftsIn a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces ...
Former WWE star Samu Anoa’i’s health has been failing him, and he is in desperate need of an open-heart surgery, according to ...
3d
News Medical on MSNVancomycin could offer new therapeutic option for patients with a type of inflammatory bowel diseaseAn antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
Unlocking the Secrets of Cancer Metastasis: Study Provides New Insights, Potential Therapeutic Opportunities Oct. 30, 2024 — Metastasis remains the primary challenge to reducing cancer deaths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results